HEART FAILURE MANAGEMENT 2008: Current Therapy and Future Trends
September 20, 2008 Welcome to the Morehouse School of Medicine, Community Physicians’ Network (CPN) and the Section of Cardiology, Department of Medicine continuing medical education (CME) program, Heart Failure Management 2008: Current Therapy and Future Trends. This half-day symposium is designed to provide a comprehensive review of the current management strategies for heart failure. It will provide a critical appraisal of well established and emerging heart failure therapy. Our goal is to equip you with the information you need to provide optimal care to your patients with heart failure. We have assembled a faculty of experts in the treatment of heart failure who will provide attendees with a comprehensive overview of the most current therapy. This will include the strategies for managing fluid overload in the heart failure patient. We would like to thank the faculty and staff of the Community Physicians’ Network, the Section of Cardiology, and the Clinical Research Center at Morehouse School of Medicine, the staff of the Georgia Tech Hotel and Conference Center as well as Global Village Management Consulting. We are grateful to the Medtronic Foundation for support of the Community Physicians’ Network. We acknowledge unrestricted educational grants to support this CME program from Merck, Boston Scientific Corporation, St. Jude Medical, Sorin Group, Astellas, Biotronik Inc., CHF Solutions Inc and Norvatis Pharmaceuticals Corporation. Sincerely, Program Co-Chairs Registration Information
There is no fee to attend this meeting; however, advance registration is required. Here are the ways you may register for this event: - BEST OPTION: Register online by clicking here
- Download the brochure, complete the registration form and fax to: 888.468.7781
Should you have any questions about registration, please email the organizers at HFMsymposium@globalvillagemc.com or call 770.573.4828 or 877.865.5830. AGENDA 7:30 AM Registration and Continental Breakfast 8:00 AM Opening Remarks Session I: Fluid Management in Heart Failure. Moderator: Dr. Abiodun Olatidoye 8:10AM Role of Hyponatremia and Fluid Overload in Worsening Patient Outcome. Dr. Chamberlain Obialo 8:30 AM Current and Emerging Strategies to Reduce Congestion in Heart Failure: New Drugs and Devices Dr. Santosh Menon 8:50 AM Cardio-Renal Syndrome - Definition, Pathophysiology and Management. Dr. Andrew Smith 9:10AM Panel Discussion 9:30AM BREAK/VISIT EXHIBITS Session II: Neurohormonal Modulation in Heart Failure. Moderator: Dr. Adefisayo Oduwole 10:00 AM RAAS antagonism. Current Approach and Emerging Trends; Pro Renin and Attacking at its Point of Activation. Dr. Elizabeth Ofili 10:20 AM Adrenergic Blockade. Does it matter how? Dr. Paul Douglass 10:40 AM Is Natriuretic Peptide Useful to Guide Therapy in Heart Failure? Dr. Nirav Raval 11:00 AM Panel Discussion Session III: Electrical and Surgical Treatment of Heart Failure. Moderator: Dr. Joseph Poku 11:20 AM Electrical Therapy in Heart Failure: An Update. Dr. David Delurgio 11:40 AM Implant ICD in all Heart Failure patients according to LV Ejection Fraction Only Protagonist: Dr. Heather Bloom Antagonist: Dr. Joseph Poku 12:00 Noon Surgical Therapy to Improve Heart Failure Outcomes. Dr. Vinod Thourani 12:20 PM Panel Discussion Lunch and Learn: 12:40 PM The Heart Failure Network Clinical Trials: Meet the Investigators: Dr. Elizabeth Ofili 1:00 PM Case Discussion: Angina in the Heart Failure Patient: What are the Therapeutic Options? Acute Diastolic Heart Failure. Treatment Options. Dr. Anekwe Onwuanyi 1:30 PM Adjourn Program Overview
The treatment of heart failure continues to evolve with the integration of the results from landmark clinical trials into contemporary therapy. The recent re-evaluation of diuretic therapy in heart failure has lead to emerging strategies for the treatment of congestion in the heart failure patient. Furthermore, there has been tremendous growth in the utilization of devices in the treatment of chronic heart Failure. Consequently, healthcare providers caring for heart failure patients require periodic review of all the available treatment strategies in order to provide the best care for their patients. This symposium will review the established therapy in chronic heart failure and discuss emerging trends in pharmacologic and device therapy. Target Audience
This educational program is designed for cardiologists, internists, primary care physicians, cardiology fellows, residents in internal medicine and family medicine, nurses and other healthcare professionals Learning Objectives
At the conclusion of this program, participants should be able to: - Understand the importance of maintaining fluid and electrolyte balance in heart failure patients.
- Learn the limitations of diuretics in treating fluid overload and the emerging strategies for relieving congestion in heart failure
- Review the neurohormonal mechanisms in heart failure. Understand the role of electrical and surgical therapies in management of heart failure
Accreditation
The Morehouse School of Medicine designates this educational activity for 4.5 hours in AMA PRA Category 1 credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Howard University Continuing Education (HUCE) has been reviewed and approved as an Authorized Provider of Continuing Education and Training by the International Association for Continuing Education and Training (IACET) and has agreed to provide CEU’s for the “Morehouse School of Medicine,” Heart Failure Management 2008: Current Therapy and Future Trends, September 20, 2008. Participants may receive 0.45 CEUs for this conference. Disclaimer
Morehouse School of Medicine (MSM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by MSM for fair balance, scientific objectivity of studies mentioned in the materials used as the basis of content, and appropriateness of patient care recommendations. |
